Cargando…

Prevalence and genetic profiles of isoniazid resistance in tuberculosis patients: A multicountry analysis of cross-sectional data

BACKGROUND: The surveillance of drug resistance among tuberculosis (TB) patients is central to combatting the global TB epidemic and preventing the spread of antimicrobial resistance. Isoniazid and rifampicin are two of the most powerful first-line anti-TB medicines, and resistance to either of them...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dean, Anna S., Zignol, Matteo, Cabibbe, Andrea Maurizio, Falzon, Dennis, Glaziou, Philippe, Cirillo, Daniela Maria, Köser, Claudio U., Gonzalez-Angulo, Lice Y., Tosas-Auget, Olga, Ismail, Nazir, Tahseen, Sabira, Ama, Maria Cecilia G., Skrahina, Alena, Alikhanova, Natavan, Kamal, S. M. Mostofa, Floyd, Katherine
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6974034/ https://www.ncbi.nlm.nih.gov/pubmed/31961877 http://dx.doi.org/10.1371/journal.pmed.1003008

Ejemplares similares

Population-based resistance of Mycobacterium tuberculosis isolates to pyrazinamide and fluoroquinolones: results from a multicountry surveillance project
por: Zignol, Matteo, et al.
Publicado: (2016)

Population structure, biogeography and transmissibility of Mycobacterium tuberculosis
por: Freschi, Luca, et al.
Publicado: (2021)

25 years of surveillance of drug-resistant tuberculosis: achievements, challenges, and way forward
por: Dean, Anna S, et al.
Publicado: (2022)

Genetic sequencing for surveillance of drug resistance in tuberculosis in highly endemic countries: a multi-country population-based surveillance study
por: Zignol, Matteo, et al.
Publicado: (2018)

Multidrug-resistant tuberculosis in children: evidence from global surveillance
por: Zignol, Matteo, et al.
Publicado: (2013)

Advances in clinical trial design for development of new TB treatments—Translating international tuberculosis treatment guidelines into national strategic plans: Experiences from Belarus, South Africa, and Vietnam
por: Brigden, Grania, et al.
Publicado: (2019)

Isoniazid Resistance in Mycobacterium tuberculosis Is a Heterogeneous Phenotype Composed of Overlapping MIC Distributions with Different Underlying Resistance Mechanisms
por: Ghodousi, Arash, et al.
Publicado: (2019)

Quantifying the Burden and Trends of Isoniazid Resistant Tuberculosis, 1994–2009
por: Jenkins, Helen E., et al.
Publicado: (2011)

Validation of Bedaquiline Phenotypic Drug Susceptibility Testing Methods and Breakpoints: a Multilaboratory, Multicountry Study
por: Kaniga, Koné, et al.
Publicado: (2020)

The impact of the COVID-19 pandemic on the global tuberculosis epidemic
por: Falzon, Dennis, et al.
Publicado: (2023)

Updating the WHO target product profile for next-generation Mycobacterium tuberculosis drug susceptibility testing at peripheral centres
por: MacLean, Emily Lai-Ho, et al.
Publicado: (2023)

World Health Organization recommendations on the treatment of drug-resistant tuberculosis, 2020 update
por: Mirzayev, Fuad, et al.
Publicado: (2021)

1653. Estimation of country-specific tuberculosis antibiograms using a wide and deep neural net on a large genomic dataset
por: Dixit, Avika, et al.
Publicado: (2020)

World Health Organization treatment guidelines for drug-resistant tuberculosis, 2016 update
por: Falzon, Dennis, et al.
Publicado: (2017)

Isoniazid resistance profile and associated levofloxacin and pyrazinamide resistance in rifampicin resistant and sensitive isolates/from pulmonary and extrapulmonary tuberculosis patients in Pakistan: A laboratory based surveillance study 2015-19
por: Tahseen, Sabira, et al.
Publicado: (2020)

Diagnostic Performance of the New Version (v2.0) of GenoType MTBDRsl Assay for Detection of Resistance to Fluoroquinolones and Second-Line Injectable Drugs: a Multicenter Study
por: Tagliani, Elisa, et al.
Publicado: (2015)

Multicountry cholera outbreak alert in Kenya: Current efforts and recommendations
por: Anis, Heeba, et al.
Publicado: (2023)

Evaluation of a novel line probe assay to detect resistance to pyrazinamide, a key drug used for tuberculosis treatment()
por: Driesen, M., et al.
Publicado: (2018)

In vivo microevolution of Mycobacterium tuberculosis and transient emergence of atpE_Ala63Pro mutation during treatment in a pre-XDR TB patient
por: Ghodousi, Arash, et al.
Publicado: (2022)

Alarming levels of drug-resistant tuberculosis in Belarus: results of a survey in Minsk
por: Skrahina, Alena, et al.
Publicado: (2012)

Tuberculosis Notification Trends and Treatment Outcomes in Penitentiary and Civilian Health Care Sectors in the WHO European Region
por: Dadu, Andrei, et al.
Publicado: (2021)

Mpox in Children and Adolescents during Multicountry Outbreak, 2022–2023
por: Hoxha, Ana, et al.
Publicado: (2023)

Indicators of Family Care for Development for Use in Multicountry Surveys
por: Kariger, Patricia, et al.
Publicado: (2012)

Heat Wave and Mortality: A Multicountry, Multicommunity Study
por: Guo, Yuming, et al.
Publicado: (2017)

Trends in tuberculosis in the UK
por: Glaziou, Philippe, et al.
Publicado: (2018)

Isoniazid and alopecia
por: Wiwanitkit, Somsri, et al.
Publicado: (2011)

Culture and Next-generation sequencing-based drug susceptibility testing unveil high levels of drug-resistant-TB in Djibouti: results from the first national survey
por: Tagliani, Elisa, et al.
Publicado: (2017)

Multidrug-resistant tuberculosis around the world: what progress has been made?
por: Falzon, Dennis, et al.
Publicado: (2015)

Bedaquiline Phenotypic and Genotypic Susceptibility Testing, Work in Progress!
por: Tiberi, Simon, et al.
Publicado: (2018)

Temporal Variation in Heat–Mortality Associations: A Multicountry Study
por: Gasparrini, Antonio, et al.
Publicado: (2015)

Changes in Susceptibility to Heat During the Summer: A Multicountry Analysis
por: Gasparrini, Antonio, et al.
Publicado: (2016)

Lessons from a recent multicountry iatrogenic botulism outbreak
por: Anniballi, Fabrizio
Publicado: (2023)

Acquisition of Cross-Resistance to Bedaquiline and Clofazimine following Treatment for Tuberculosis in Pakistan
por: Ghodousi, Arash, et al.
Publicado: (2019)

Isoniazid-induced alopecia
por: Gupta, K. B., et al.
Publicado: (2011)

Alopecia caused by isoniazid
por: Dixit, Ramakant, et al.
Publicado: (2014)

Isoniazid and Pulmonary Fibrosis
por: Chung, Chae Uk, et al.
Publicado: (2015)

Isoniazid metabolism and hepatotoxicity
por: Wang, Pengcheng, et al.
Publicado: (2016)

Impact of Isoniazid Resistance-Conferring Mutations on the Clinical Presentation of Isoniazid Monoresistant Tuberculosis
por: Dantes, Raymund, et al.
Publicado: (2012)

Multicountry clinical outcomes of a new nondiffractive presbyopia-correcting IOL
por: Bala, Chandra, et al.
Publicado: (2022)

A multicountry measure of comovement and contagion in international markets: definition and applications
por: Tessler, Nina, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_hp1k2e2rsnspfovi351glbkfpr